Drug Discovery & Development
Identification of antibody cross-reactivity
Based on a technique that analyses the similarity of sequences and the structure of CDR (Complementarity Determining Region) of known antibodies and a new antibody. It allows identify possible cross-reactions of an antibody with other proteins ("off target"). These reactions may be positive or negative, but their knowledge is essential before the start of a clinical trial.
• Antibody sequence
Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.
Please answer all questions below to specify your requirements
Please answer all questions. If you are not logged in, you will be redirected.